AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
+6.8%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$96.6M
AUM Growth
+$96.6M
(-6.7%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-12.35%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$6.09M |
| 2 |
Kura Oncology
KURA
|
$4.92M |
| 3 |
BLPH
Bellerophon Therapeutics, Inc.
BLPH
|
$631K |
| 4 |
AKAO
Achaogen, Inc.
AKAO
|
$285K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
| $41.2M | 42.64% |
2,618,351
| – | – |
|
|
2
Kura Oncology
KURA
$690M
| $26.7M | 27.65% |
1,356,307
-250,000
| -16% | -$4.92M |
|
|
3
Fate Therapeutics
FATE
$119M
| $19.8M | 20.45% |
973,190
-300,000
| -24% | -$6.09M |
|
|
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $8.94M | 9.26% |
1,196,776
| – | – |
|
|
BLPH
5
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| – | – |
-965,660
| Closed | -$631K |
|
|
AKAO
6
DELISTED
Achaogen, Inc.
AKAO
| – | – |
-624,544
| Closed | -$285K |
|